Skip to main content

Table 4 Baseline characteristics of ARDS patients in different MLR levels

From: Monocyte-to-lymphocyte ratio is associated with 28-day mortality in patients with acute respiratory distress syndrome: a retrospective study

Variables

Low MLR

(MLR < 0.90, n = 186)

High MLR

(MLR ≥ 0.90, n = 82)

P value

Age (years)

67 (60.75–72)

68 (62–73)

0.448

Male, n (%)

131 (70.4)

61 (74.4)

0.507

Smoking, n (%)

61 (32.8)

24 (29.3)

0.567

Alcohol abuse, n (%)

47 (25.3)

16 (19.5)

0.306

Hypertension, n (%)

82 (44.1)

34 (41.5)

0.690

Diabetes mellitus, n (%)

50 (26.9)

24 (29.3)

0.687

Coronary artery disease, n (%)

39 (21)

15 (18.3)

0.615

Risk factor, n (%)

  

0.263

 Pneumonia

167 (89.7)

79 (96.3)

 

 Aspiration

8 (4.3)

2 (2.4)

 

 Sepsis

5 (2.8)

1 (1.3)

 

 Others

6 (3.2)

0 (0)

 

Types of infection, n (%)

  

0.629

 Bacteria

138 (74.2)

65 (79.3)

 

 Virus

7 (3.8)

1 (1.2)

 

 Fungus

26 (14)

11 (13.4)

 

 Unknown

15 (8)

5 (6.1)

 

PaO2/FiO2 (mmHg)

142 (101–194)

138 (87.61–184.25)

0.386

Categories of ARDS, n (%)

  

0.546

 Mild

40 (21.5)

17 (20.7)

 

 Moderate

101 (54.3)

40 (48.8)

 

 Severe

45 (24.2)

25 (30.5)

 

WBC, 109/L

9.56 (6.86–11.75)

9.7 (6.67–11.89)

0.944

Hemoglobin, g/L

112.5 (98–129.25)

105 (91.5–124.25)

0.091

RDW, %

13.75 (12.9–15.1)

13.9 (13–14.9)

0.775

Lactate, mmol/L

2.2 (1.4–3.83)

2.6 (1.5–3.73)

0.192

Albumin, g/L

32.9 (28.9–37.7)

32.15 (28.58–37.3)

0.349

MLR

0.41 (0.26–0.59)

1.49 (1.15–2.24)

<0.001

NLR

8.45 (4.47–16.09)

20.62 (13.11–35.12)

<0.001

RDW/albumin, %/g/L

0.43 (0.36–0.51)

0.43 (0.37–0.49)

0.903

AST

50.45 (21.03–139.13)

75.25 (28.7–151.78)

0.106

ALT

54.55 (20–125.93)

62.45 (25.28–149.53)

0.465

Cr, μmol/L

94.35 (58.28–181.88)

134.7 (71.78–197.98)

0.025

BUN, mmol/L

13.28 (7.4–17.8)

13.57 (9.79–19.2)

0.154

APACHE II score

12 (9–16)

14 (10–17.25)

0.308

SOFA score

7 (6–9)

8 (7–9)

0.046

Interventions, n (%)

   

 Steroida

129 (69.4)

55 (67.1)

0.711

 Hypoglycemic

58 (31.2)

23 (28)

0.607

 Alimentotherapy

113 (60.8)

66 (80.5)

0.002

 Albumin infusion

82 (44.1)

55 (67.1)

0.001

 Transfusion

51 (27.4)

32 (39)

0.058

 CRRT

23 (12.4)

16 (19.5)

0.126

 ECMO

7 (3.8)

4 (4.9)

0.672

 Mechanical ventilation

109 (58.6)

50 (61)

0.715

28-day mortality, n (%)

38 (20.4)

47 (57.3)

<0.001

Duration of ventilation

6 (2–12)

10 (3.75–14)

0.008

Hospital length of stay

19 (12–24.25)

18.5 (12.75–25)

0.787

  1. aSteroid therapy was defined as at least a dose (≥ 0.5mg/kg) of methylprednisolone during hospitalization
  2. ARDS, acute respiratory distress syndrome; WBC, white blood cell; RDW, red cell distribution width; MLR, monocyte-to-lymphocyte ratio; NLR, neutrophil-to-lymphocyte ratio; AST, aspartate aminotransferase; ALT, alanine aminotransferase; Cr, creatinine; BUN, blood urea nitrogen; APACHE II, Acute Physiology and Chronic Health Evaluation II; SOFA, Sequential Organ Failure Assessment; CRRT, continuous renal replacement therapy; ECMO, extracorporeal membrane oxygenation